Idea, Development, Exploration, Assessment, Long‐term follow‐up study (IDEAL) Stage 1/2a evaluation of urological procedures with the Versius robot

The da Vinci surgical system (Intuitive Surgical Inc., Sunnyvale, CA, USA) has held the majority market share in surgical robotics since it first obtained United States Food and Drug Administration (FDA) approval in the year 2000. However, new robotic systems are beginning to enter the clinical arena [1,2]. The Cambridge Medical Robotics Surgical (CMR) Versius system is the first commercially available UKbased robotic platform. It has a modular design, with an open console and three or four individual bedside units (BSU) that control 5-mm wristed robotic instruments.